Research Presentation Session
RPS 307 - Genitourinary cancers
Lectures
1
RPS 307 - Quantitative diffusion-weighted MR imaging in preoperative evaluation of endometrial cancer: the correlation between apparent diffusion coefficient (ADC) and definitive histological grade
04:53E. Scibilia, Catania / Italy
2
RPS 307 - Synthetic MRI for quantitative measurements of endometrial cancer and correlation with depth of myometrial invasion
04:20Y. Wang, Hong Kong / China
3
RPS 307 - Comparison of abdominal attenuation values on virtual unenhanced image obtained with renal mass to hematuria dual-energy computed tomography protocol
04:55J. Cao, Boston, MA / United States
4
RPS 307 - Diagnostic accuracy of the ADNEX MRI scoring system based on a simplified MRI protocol: preliminary results of a single tertiary center retrospective study
07:20S. Aslan, Giresun / Turkey
5
RPS 307 - Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses
04:29I. Baldi, Florence / Italy
6
RPS 307 - Ex vivo 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy for early prostate cancer detection
05:06A. Steiner, Ulm / Germany
7
RPS 307 - Non-prostate cancer tumours: incidence on 18F DCFPyL PSMA PET/CT and uptake characteristics
05:06E. Perry, Christchurch / New Zealand
8
RPS 307 - 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence after primary treatment: diagnostic performance and impact on management strategy
03:51R. Wang, Chengdu / China
9
RPS 307 - Making an art into a science: a mathematical “Likert tool” can change PI-RADS (v2) scores into Likert scores when reporting mpMRI for prostate cancer
05:06W. Stevens, Huddersfield / UK
10
RPS 307 - Follow-up for women after treatment for cervical cancer: a study about 418 patients
07:47R. Taoussi, Casablanca / Morocco
11
RPS 307 - Role of radiomics in the evaluation of PI-RADS 3 lesions
05:17D. Nicoletta, Merate / Italy
12
RPS 307 - Risk stratification of PIRADS 3 nodules using clinical/radiological characteristics in comparison to histopathological gold standard
04:05F. Monelli, Reggio Emilia / Italy
13
RPS 307 - 18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsies
05:07L. Davis, London / UK